Gyre Therapeutics, Inc. SEC filings GYRE
Gyre Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Sep 10, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 27, 2026 | — |
| S-3/A | Filing | Jul 13, 2026 | — |
| S-3 | Shelf registration | Jun 23, 2026 | — |
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| 424B5 | Prospectus supplement | May 23, 2025 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Nov 27, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| S-3 | Shelf registration | May 30, 2024 | — |
| S-3 | Shelf registration | May 30, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | Nov 13, 2023 | — |
| 424B3 | Prospectus | Nov 1, 2023 | — |
| S-8 | Employee stock plan registration | Oct 31, 2023 | — |
| 424B3 | Prospectus | Oct 27, 2023 | — |
| S-3/A | Form s-3/a | Oct 24, 2023 | — |
| S-3/A | Filing | Oct 13, 2023 | — |
| S-3 | Shelf registration | Jul 24, 2023 | — |
| S-8 | Employee stock plan registration | Mar 31, 2022 | — |
| 424B5 | Prospectus supplement | Oct 15, 2021 | — |
| S-3 | Shelf registration | Mar 4, 2021 | — |
| 424B5 | Prospectus supplement | Jan 28, 2021 | — |
| 424B5 | Prospectus supplement | Jan 26, 2021 | — |
| S-8 | Employee stock plan registration | Jul 6, 2020 | — |
| 424B5 | Prospectus supplement | Jun 19, 2020 | — |
| 424B5 | Prospectus supplement | Jun 17, 2020 | — |
| 424B5 | Prospectus supplement | Feb 14, 2020 | — |
| 424B5 | Prospectus supplement | Feb 12, 2020 | — |
| S-3 | Shelf registration | Dec 21, 2018 | — |
| S-8 | Employee stock plan registration | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Feb 14, 2018 | — |
| 424B5 | Prospectus supplement | Feb 12, 2018 | — |
| S-3 | Shelf registration | Jan 22, 2018 | — |
| 424B5 | Prospectus supplement | Dec 21, 2017 | — |
| 424B5 | Prospectus supplement | Dec 19, 2017 | — |
| S-8 | Employee stock plan registration | Jul 14, 2017 | — |
| 424B4 | Prospectus | Apr 10, 2017 | — |
| S-1MEF | Filing | Apr 6, 2017 | — |
| S-1/A | Amended registration statement | Apr 5, 2017 | — |
| S-1/A | Amended registration statement | Apr 4, 2017 | — |
| FWP | Free writing prospectus | Apr 3, 2017 | — |
| S-1/A | Amended registration statement | Mar 31, 2017 | — |
| S-1 | Registration statement | Mar 13, 2017 | — |
| S-8 | Employee stock plan registration | Jun 30, 2016 | — |
| S-3 | Shelf registration | Mar 16, 2016 | — |
| S-8 | Employee stock plan registration | Aug 21, 2015 | — |
| S-8 | Employee stock plan registration | Aug 21, 2015 | — |
| 424B3 | Prospectus | Jul 28, 2015 | — |
| S-4/A | Filing | Jul 23, 2015 | — |
| S-4/A | Filing | Jul 17, 2015 | — |
| S-4/A | Filing | Jul 1, 2015 | — |
| S-4 | Registration for a merger or exchange | May 22, 2015 | — |
| 424B3 | Prospectus | Dec 12, 2013 | — |
| 424B3 | Prospectus | Dec 12, 2013 | — |
| S-3 | Shelf registration | Nov 26, 2013 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC. (until Oct 27, 2023); TARGACEPT INC (until Aug 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.